Related Experiment Video

Updated: Jun 27, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Mcl-1 is a potential therapeutic target in multiple types of cancer

C Akgul1

  • 1Department of Chemistry, Canakkale Onsekiz Mart University, Turkey. cahitakgul@comu.edu.tr

Cellular and Molecular Life Sciences : CMLS
|December 23, 2008
PubMed

Insights

Targeting Mcl-1, a key survival protein in cancers, offers a promising strategy. Inhibiting Mcl-1 rapidly sensitizes cancer cells to apoptosis, providing new therapeutic avenues for malignancies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Resistance to apoptosis is a major hurdle in cancer treatment.
  • Mcl-1 is a pro-survival protein overexpressed in many human cancers.
  • Targeting molecular mechanisms of cell survival is a key therapeutic strategy.

Purpose of the Study:

  • To review the regulation of Mcl-1 expression in human malignancies.
  • To discuss therapeutic strategies targeting Mcl-1 in cancer cells.
  • To highlight Mcl-1 as a vulnerability in Mcl-1-dependent cancers.

Main Methods:

  • Literature review of Mcl-1 regulation.
  • Analysis of therapeutic approaches targeting Mcl-1.
  • Summary of current knowledge on Mcl-1's role in cancer.

Main Results:

  • Mcl-1 has a short half-life, making it a rapidly targetable protein.
  • Inhibition of Mcl-1 expression or function increases apoptosis susceptibility.
  • Mcl-1-dependent cancer cells are vulnerable to Mcl-1 targeting.

Conclusions:

  • Mcl-1 is a critical regulator of apoptosis in cancer.
  • Targeting Mcl-1 presents a viable therapeutic strategy for various cancers.
  • Understanding Mcl-1 regulation is key to developing effective anti-cancer treatments.

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma08:31

Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma

Published on: September 12, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...